Abstract
A TEM-1 β-lactamase derivative containing the single amino acid substitution A237T slightly increased (from 24 to 32 μg/ml) the cephalothin MIC for Escherichia coli RYC1000 but did not influence the activities of cefotaxime, ceftazidime, and aztreonam (MICs of 0.03, 0.12, and 0.06 μg/ml, respectively). Despite its apparent neutrality, addition of the A237T mutation to the pair of mutations characterizing TEM-10 (R164S and E240K) had a strong effect on substrate preference. Ceflazidime and aztreonam MICs decreased from 128 and 16 μg/ml to 16 and 2 μg/ml, respectively. In contrast, the cefotaxime MIC increased from 0.5 to 4 μg/ml. The acquisition of apparently neutral or even deleterious mutations results in a very effective mechanism of resistance to different β-lactams that may be simultaneously or subsequently present in the environment. We propose here that the mutation in position 237 is an example of a modulating mutation and that consideration of this type of mutation may be important for understanding the evolution of β-lactamases.
Cite
CITATION STYLE
Blázquez, J., Negri, M. C., Morosini, M. I., Gómez-Gómez, J. M., & Baquero, F. (1998). A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type β-lactamases. Antimicrobial Agents and Chemotherapy, 42(5), 1042–1044. https://doi.org/10.1128/aac.42.5.1042
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.